| Date | Title | Description | Source |
| 08.03.2024 | Onconova Therapeutics’ Rigosertib Poster Selected for AACR 2... | - | globenewsw... |
| 03.12.2021 | ONCONOVA THERAPEUTICS ANNOUNCES THE PRESENTATION OF PRELIMIN... | NEWTOWN, Pa. - Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical compan... | marketscre... |
| 02.12.2021 | Onconova Therapeutics Announces the Presentation of Prelimin... | NEWTOWN, Pa., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinic... | marketscre... |
| 12.11.2021 | Onconova Therapeutics Reports Third Quarter 2021 Financial R... | NEWTOWN, Pa., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Oncono... | marketscre... |
| 12.11.2021 | Onconova Therapeutics Reports Third Quarter 2021 Financial R... | Onconova Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update
Conf... | marketscre... |
| 28.09.2021 | Onconova Therapeutics : Announces Closing of $21 Million Pub... | NEWTOWN, Pa., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Oncono... | marketscre... |
| 27.09.2021 | ONCONOVA THERAPEUTICS : ANNOUNCES PRICING OF $21 MILLION PUB... | NEWTOWN, Pa. - Onconova Therapeutics, Inc. (NASDAQ: ONTX) ('Onconova'), a biopharmaceutical company ... | marketscre... |
| 24.09.2021 | ONCONOVA THERAPEUTICS : ANNOUNCES PROPOSED PUBLIC OFFERING O... | NEWTOWN, Pa. - Onconova Therapeutics, Inc. (NASDAQ: ONTX) ('Onconova'), a biopharmaceutical company ... | marketscre... |
| 24.09.2021 | Onconova Therapeutics : Announces Pricing of $21 Million Pub... | Onconova Therapeutics, Inc. Announces Pricing of $21 Million Public Offering of Common Stock
NEWTOWN... | marketscre... |
| 24.09.2021 | Onconova Therapeutics : Inc. Announces Pricing of $21 Millio... | NEWTOWN, Pa., Sept. 24, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Oncono... | marketscre... |
| 23.09.2021 | Onconova Therapeutics : Inc. Announces Proposed Public Offer... | NEWTOWN, Pa., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Oncono... | marketscre... |
| 22.09.2021 | Onconova Therapeutics : Announces Encouraging Clinical Data ... | Onconova Therapeutics Announces Encouraging Clinical Data Supporting the Anti-Cancer Activity of Rig... | marketscre... |
| 22.09.2021 | Onconova Therapeutics : Announces Encouraging Clinical Data ... | Preliminary Phase 1/2a trial data show an early signal of activity in extensively pre-treated popula... | marketscre... |
| 20.09.2021 | Onconova Therapeutics : Announces Upcoming Presentation at t... | NEWTOWN, Pa., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clini... | marketscre... |
| 10.09.2021 | Onconova Therapeutics : Announces Participation At The Upcom... | NEWTOWN, Pa. - Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical compan... | marketscre... |
| 17.06.2021 | ONCONOVA THERAPEUTICS, INC.
Onconova Therapeutics : Announc... | Rigosertib synergistically combined with immune checkpoint blockade (ICB) to improve tumor growth in... | marketscre... |
| 11.06.2021 | ONCONOVA THERAPEUTICS, INC.
ONCONOVA THERAPEUTICS : ANNOUNC... | NEWTOWN, Pa. - Onconova Therapeutics, Inc. (NASDAQ: ONTX) ('Onconova'), a clinical-stage biopharmace... | marketscre... |
| 10.06.2021 | ONCONOVA THERAPEUTICS, INC.
Onconova Therapeutics : Announc... | NEWTOWN, Pa., June 10, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconov... | marketscre... |
| 03.06.2021 | ONCONOVA THERAPEUTICS, INC.
Onconova Therapeutics : Announc... | NEWTOWN, Pa., June 03, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconov... | marketscre... |
| 01.06.2021 | ONCONOVA THERAPEUTICS, INC.
Onconova Therapeutics : Announc... | NEWTOWN, Pa., June 01, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconov... | marketscre... |
| 24.05.2021 | ONCONOVA THERAPEUTICS, INC.
ONCONOVA THERAPEUTICS : ANNOUNC... | NEWTOWN, Pa. - Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical compan... | marketscre... |
| 21.05.2021 | ONCONOVA THERAPEUTICS, INC.
Onconova Therapeutics : Announc... | NEWTOWN, Pa., May 21, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinica... | marketscre... |
| 21.05.2021 | ONCONOVA THERAPEUTICS, INC.
ONCONOVA THERAPEUTICS : ANNOUNC... | NEWTOWN, Pa. - Onconova Therapeutics, Inc. (Nasdaq: ONTX) ('Onconova' or 'the Company'), a clinical-... | marketscre... |
| 20.05.2021 | ONCONOVA THERAPEUTICS, INC.
Onconova Therapeutics : Announc... | NEWTOWN, Pa., May 20, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq: ONTX) (“Onconova... | marketscre... |
| 22.04.2021 | ONCONOVA THERAPEUTICS, INC.
Onconova Therapeutics : Announc... | NEWTOWN, Pa., April 22, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clini... | marketscre... |
| 01.04.2021 | ONCONOVA THERAPEUTICS, INC.
Onconova Therapeutics : Announc... | NEWTOWN, Pa., April 01, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clini... | marketscre... |
| 12.03.2021 | ONCONOVA THERAPEUTICS, INC.
Onconova Therapeutics Reports F... | Conference call begins at 4:30 p.m. Eastern time today
NEWTOWN, Pa., March 11, 2021 (GLOBE NEWSWIRE)... | marketscre... |
| 10.02.2021 | Onconova Therapeutics, Inc. Announces Pricing of $25 Million... | NEWTOWN, Pa., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconov... | globenewsw... |
| 13.08.2020 | Mission Bio Lands $70M to Expand Cancer Therapies With Singl... | What You Should Know:
– Mission Bio raises $70 million in Series C funding led by Novo Growth to acc... | hitconsult... |
| 15.01.2014 | Temple University’s 12 active spinout startups have raised $... | Temple University‘s 12 active spinout startups have raised $336 million total in the past 15 years, ... | technical.... |
| 20.06.2013 | PTC Therapeutics joins the IPO scrum as more biotechs take a... | The nonsense mutation is the cause of Duchenne muscular dystrophy in about 13 percent of patients, o... | medcitynew... |
| 06.10.2010 | Onconova Therapeutics raises $6.5M for pre-leukemia therapy | Led by Ramesh Kumar, who is chief executive and president, Onconova said Monday it had agreed (pdf) ... | medcitynew... |
| - | PTC Therapeutics joins the IPO scrum as more biotechs take a... | It may not be the most complimentary assessment of a biotech’s initial public offering to say that i... | medcitynew... |
| - | Onconova Therapeutics raises $6.5M for pre-leukemia therapy | Newton, Pennsylvania, biotechnology company Onconova Therapeutics Inc. in has raised $6.5 million in... | medcitynew... |
